Aerie Pharmaceuticals DB:0P0 Rapport sur les actions
Dernier prix
€14.50
Capitalisation boursière
€735.5m
7D
0%
1Y
63.8%
Mise à jour
21 Nov, 2022
Données
Finances de l'entreprise +
Aerie Pharmaceuticals, Inc.
DB:0P0 Rapport sur les actions
Capitalisation boursière : €735.5m
This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
0P0 Aperçu des actions
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States.